Organon (OGN) Total Current Liabilities (2020 - 2026)

Organon (OGN) recorded quarterly Total Current Liabilities of $2.5 billion in Q1 2026, up 4.6% quarter-over-quarter from $2.4 billion in Q4 2025, and down 4.4% on a YoY basis from $2.6 billion in Q1 2025.

Organon (OGN) Total Current Liabilities (2020 - 2026) Analysis & Trends

Organon's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $2.5 billion for Q1 2026.

  • In Q1 2026, Total Current Liabilities fell 4.4% year-over-year to $2.5 billion; the TTM figure through Mar 2026 stood at $2.5 billion (down 4.4% YoY), while the FY2025 annual figure was $2.4 billion, down 12.07% from the prior year.
  • Total Current Liabilities was $2.5 billion for Q1 2026 at Organon, up from $2.4 billion in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $2.9 billion in Q4 2023 to a low of $2.3 billion in Q1 2022.
  • Historically, Total Current Liabilities has averaged $2.6 billion across 5 years, with a median of $2.5 billion in 2022.
  • The sharpest annual moves came in 2022 and 2023: Total Current Liabilities fell 25.6% in 2022, then grew 16.16% in 2023.
  • A 5-year view of Total Current Liabilities shows it stood at $2.5 billion in 2022, then gained by 16.16% to $2.9 billion in 2023, then retreated by 6.85% to $2.7 billion in 2024, then dropped by 12.07% to $2.4 billion in 2025, then grew by 4.6% to $2.5 billion in 2026.
  • The last three Total Current Liabilities figures came in at $2.5 billion (Q1 2026), $2.4 billion (Q4 2025), and $2.7 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Gsk 93,026,132.38 Bn 93,026,127.42 Bn 7.76 Bn -30.24 Bn
2 Eli Lilly 1,022.62 Bn 1,017.34 Bn 16.22 Bn 36.63 Bn
3 Johnson & Johnson 570.65 Bn 548.59 Bn 15.96 Bn 57.72 Bn
4 AbbVie 398.73 Bn 389.38 Bn 10.78 Bn 42.10 Bn
5 Merck 295.53 Bn 289.88 Bn 12.09 Bn 26.95 Bn
6 Amgen 186.30 Bn 174.26 Bn 5.87 Bn 24.96 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn 9.48 Bn
8 Pfizer 146.09 Bn 133.32 Bn -1.21 Bn 34.35 Bn
9 Bristol Myers Squibb 114.98 Bn 104.53 Bn 8.07 Bn 19.16 Bn
10 Organon 3.49 Bn 2.37 Bn 783.00 Mn 2.50 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.50 Bn
Dec 31, 2025 2.39 Bn
Sep 30, 2025 2.68 Bn
Jun 30, 2025 2.80 Bn
Mar 31, 2025 2.62 Bn
Dec 31, 2024 2.72 Bn
Sep 30, 2024 2.79 Bn
Jun 30, 2024 2.76 Bn
Mar 31, 2024 2.55 Bn
Dec 31, 2023 2.92 Bn
Sep 30, 2023 2.49 Bn
Jun 30, 2023 2.39 Bn
Mar 31, 2023 2.35 Bn
Dec 31, 2022 2.51 Bn
Sep 30, 2022 2.33 Bn
Jun 30, 2022 2.40 Bn
Mar 31, 2022 2.31 Bn
Dec 31, 2021 2.60 Bn
Sep 30, 2021 3.13 Bn
Jun 30, 2021 2.98 Bn